Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 196, Issue 7, Pages 1088-1092Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/521367
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01RR-00037, M01 RR000037] Funding Source: Medline
- NHLBI NIH HHS [K08HL67903, K08 HL067903-02, K08 HL067903-04, K08 HL067903-03, K08 HL067903-05, K08 HL067903, K08 HL067903-01] Funding Source: Medline
- NIAID NIH HHS [AI047938, R01 AI047938, R01 AI047938-08] Funding Source: Medline
- PHS HHS [K064954] Funding Source: Medline
Ask authors/readers for more resources
Three structural features of lipid A ( addition of palmitate [C16 fatty acid], addition of aminoarabinose [ positively charged amino sugar residue], and retention of 3-hydroxydecanoate [3-OH C10 fatty acid]) were determined for Pseudomonas aeruginosa isolates from patients with cystic fibrosis (CF; n = 86), from the environment (n = 13), and from patients with other conditions (n = 13). Among P. aeruginosa CF isolates, 100% had lipid A with palmitate, 24.6% with aminoarabinose, and 33.3% retained 3- hydroxydecanoate. None of the isolates from the environment or from patients with other conditions displayed these modifications. These results indicate that unique lipid A modifications occur in clinical P. aeruginosa CF isolates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available